Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Comparative Study of JTT-751 with Sodium Ferrous Citrate in Patients with Iron Deficiency Anemia

Trial Profile

A Comparative Study of JTT-751 with Sodium Ferrous Citrate in Patients with Iron Deficiency Anemia

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric citrate (Primary) ; Sodium ferrous citrate
  • Indications Iron deficiency anaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Japan Tobacco
  • Most Recent Events

    • 10 Jul 2019 According to an Akebia Therapeutics media release, Akebia Therapeutics announced that its collaboration partner Japan Tobacco and its subsidiary Torii Pharmaceutical, reported positive top-line results from this study.
    • 10 Jul 2019 Results presented in an Akebia Therapeutics media release.
    • 09 Jul 2019 According to an Japan Tobacco Media Release, Japan Tobacco and Torii aim to file for an additional indication of improving iron deficiency anemia using Riona in Japan based on this and other clinical studies.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top